CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 168, Issue 4, Pages 835-849
Publisher
Wiley
Online
2012-09-07
DOI
10.1111/j.1476-5381.2012.02204.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reward, Addiction, Withdrawal to Nicotine
- (2011) Mariella De Biasi et al. Annual Review of Neuroscience
- Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice
- (2011) Dena Kota et al. BIOCHEMICAL PHARMACOLOGY
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
- (2011) S. Singh et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Modulation of the Ca2+ permeability of human endplate acetylcholine receptor-channel
- (2011) Vanessa Piccari et al. CELL CALCIUM
- Design, Synthesis, and Pharmacological Characterization of Novel Spirocyclic Quinuclidinyl-Δ2-Isoxazoline Derivatives as Potent and Selective Agonists of α7 Nicotinic Acetylcholine Receptors
- (2011) Clelia Dallanoce et al. ChemMedChem
- Engineering of α-conotoxin MII-derived peptides with increased selectivity for native α6β2* nicotinic acetylcholine receptors
- (2011) Luca Pucci et al. FASEB JOURNAL
- Unichiral 2-(2′-Pyrrolidinyl)-1,4-benzodioxanes: the 2R,2′SDiastereomer of theN-Methyl-7-hydroxy Analogue Is a Potent α4β2- and α6β2-Nicotinic Acetylcholine Receptor Partial Agonist
- (2011) Cristiano Bolchi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Intravenous nicotine self-administration and cue-induced reinstatement in mice: Effects of nicotine dose, rate of drug infusion and prior instrumental training
- (2011) Christie D. Fowler et al. NEUROPHARMACOLOGY
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- Suicidal Behavior and Depression in Smoking Cessation Treatments
- (2011) Thomas J. Moore et al. PLoS One
- 86 Rb + efflux mediated by α4β2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization
- (2010) Michael J. Marks et al. BIOCHEMICAL PHARMACOLOGY
- Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
- (2010) H Rollema et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nicotine addiction and nicotinic receptors: lessons from genetically modified mice
- (2010) Jean-Pierre Changeux NATURE REVIEWS NEUROSCIENCE
- Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
- (2010) Grazyna Biala et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats
- (2010) Susmita Chatterjee et al. NEUROPSYCHOPHARMACOLOGY
- Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
- (2010) Yann S. Mineur et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Nicotinic acetylcholine receptors and the ascending dopamine pathways
- (2009) Phil D. Livingstone et al. BIOCHEMICAL PHARMACOLOGY
- Structural and functional diversity of native brain neuronal nicotinic receptors
- (2009) Cecilia Gotti et al. BIOCHEMICAL PHARMACOLOGY
- Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
- (2009) Sherry A. McKee et al. BIOLOGICAL PSYCHIATRY
- Rodent Habenulo-Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the 3 4 and 3 3 4 Subtypes Mediate Acetylcholine Release
- (2009) S. R. Grady et al. JOURNAL OF NEUROSCIENCE
- The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
- (2009) Eoin C. O’Connor et al. PSYCHOPHARMACOLOGY
- Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
- (2008) Piotr Tutka EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward
- (2007) Daniela Braida et al. BIOLOGICAL PSYCHIATRY
- Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum
- (2003) Sharon R. Grady et al. JOURNAL OF NEUROCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started